CEO and Co-Founder, Tamr
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Director, Life Sciences Institute, University of Michigan
Founder and CEO of Brooks Bell Inc.
VP of Research & Policy, Ewing Marion Kauffman Foundation
Medical College of Wisconsin director of research commercialization
Professor of Systems Biology, Columbia University
Software Engineer at Skelmir
|
|
Austin—Dosh, a fintech and advertising startup that gets consumers cash back on certain purchases, has raised a $44 million Series A round of funding from some big-name investors, including PayPal.
Dosh, founded in 2016, has had an active start to... Read more »
Michigan’s innovation community continues to pump out news at a steady clip. Here are some of the latest updates from around the state.
—Ann Arbor’s Genomenon, a startup focused on genomic search data, has struck a new partnership with Boston’s ... Read more »
Farmers spend a lot of time and money trying to keep insects from damaging their crops. But the U.S. military sees some of these bugs as potential friends, not foes. A government-funded research project is studying how to use insects to... Read more »
Doctor On Demand, a startup that provides telemedicine services to patients who are unable or unwilling to see a doctor in person, says it has raised a $74 million round of outside financing.
The new cash comes as the San... Read more »
The Facebook and Cambridge Analytica data scandal may be the most prominent controversy the social networking company has had, but Jason Calacanis appears to call Facebook the “dark side” of social media for more reasons than that.
Calacanis is an angel... Read more »
Austin—BigCommerce, which sells software to allow businesses to build and run online stores, announced Wednesday that it has raised $64 million in new funding.
The investment round was led by Goldman Sachs with participation from current investors General Catalyst, GGV... Read more »
Jennifer Fonstad and Theresia Gouw launched Aspect Ventures with their own money in February 2014—and have hardly looked back. “We closed our first investment that first week,” Fonstad says. The pair went on to make a number of investments that first... Read more »
Just a few years ago, there were no drugs available for patients with the rare genetic disease spinal muscular atrophy. Now two cutting-edge therapies look headed for a commercial battle, with each data and revenue update a key moment in the... Read more »
Levodopa, the gold-standard medicine for Parkinson’s disease, has helped millions of patients since the 1970s manage the neurodegenerative disease.
But there’s a caveat. Nothing is available that can slow or reverse the loss of brain cells, and what’s more, levodopa’s effects... Read more »
For all the hype surrounding the potential for blockchain systems to transform many industries, the technology has yet to have much of an impact on businesses. But 2018 is shaping up to be a critical year for the budding sector: more... Read more »
Savari, whose technology is designed to create a shared communications web among cars, personal devices, and roadway signals, announced today it has raised $12 million in a Series B fundraising round.
Santa Clara, CA-based Savari makes V2X technology—that is, software... Read more »
Upper Hand, the Indianapolis startup focused on sports management software and business services, announced earlier this month that it has snagged $1.5 million in Series A funding from Houston, TX-based Park Ten Capital.
Company co-founder and CEO Kevin MacCauley came... Read more »
Five months after a mishap involving a delivery truck thousands of miles away prompted the cancellation of a scheduled driverless shuttle demonstration in Madison, WI, people living in and around the city have another chance to experience the potential future of... Read more »
Houston—Texas political leaders, along with heads of the Texas Medical Center and its institutions, announced on Monday plans for a biotech-focused hub that could place Houston on the map of life sciences innovation centers.
The TMC Translational Research campus, or... Read more »
As new technologies give drug developers greater insight into protein biology, more biotech and pharma companies are now emboldened to pursue what have long been dismissed as undruggable targets—the 75-85 percent of all human proteins that are beyond the reach of... Read more »
Revolution Medicines emerged three years ago to develop drugs from products found in nature and said its lead prospect would be an antifungal compound.
Redwood City, CA-based Revolution is now focused on cancer and has raised $56 million to bring a... Read more »
Eli Lilly said enough to convince an FDA advisory panel that its experimental rheumatoid arthritis drug is effective in treating the inflammatory disorder. But on safety, the independent experts were not uniformly persuaded, and they voted to recommend approval only for... Read more »
San Antonio—A life sciences professional development and advocacy group in San Antonio, The Health Cell, is hosting a three-day boot camp for researchers, scientists, and entrepreneurs who want to start or join a healthtech company.
The event is taking place... Read more »
Smart speakers are becoming increasingly common in our homes. Users can instruct these devices to order takeout, give the weather forecast, or turn on or off various Internet-connected devices.
The Consumer Technology Association estimates that nearly 44 million voice-enabled assistants will... Read more »
Formlabs sees China as one of the keys to expanding 3D printing technology’s role in manufacturing, and the Massachusetts-based startup plans to grow its business there with the help of a recent $30 million venture funding round and some new investors... Read more »
A new treatment for postpartum depression has inched closer to market.
Sage Therapeutics this morning filed for FDA approval of brexanolone, which could become the company’s first marketed product as well as the first-ever drug approved specifically for PPD, which affects... Read more »
San Antonio — For early stage researchers at universities and other institutions, the idea of finding enough money to bring a drug or medical device to market can seem daunting, if not entirely hopeless.
Grants and angel networks can cover some... Read more »
Sponsored · Whitepaper
Know Your Risk Factors and How to Address Them
RSM
Sponsored · Whitepaper
Understand who’s affected, what’s changed, and the impact on your business with the Labor Department's 'final rule' requirements for financial disclosures.
DocuSign
Sponsored · Whitepaper
Staffing companies need to invest in digital tools to recruit, hire, and onboard the best professionals faster and more efficiently.
DocuSign
The Hidden Risks of Sourcing Human Biological Samples
Scientist.com
VP of Research and Special Initiatives, Google
Managing Director, Mercury Fund
Founder and CEO, Lighter Capital
Managing Director, D.E. Shaw and Co., L.P.
Gravy Live co-founder
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
